# Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery

> **NCT03741075** · NA · UNKNOWN · sponsor: **Aswan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **PROCEDURE:** BUA
- **DRUG:** topical tranexamic acid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03741075
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03741075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03741075, "Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03741075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*